Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hidradenitis suppurativa
Samantha R. Goldburg, Bruce Strober, Michael Payette
Journal of the American Academy of Dermatology (2019) Vol. 82, Iss. 5, pp. 1045-1058
Closed Access | Times Cited: 341

Showing 1-25 of 341 citing articles:

Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials
Alexa B. Kimball, Gregor B. E. Jemec, Afsáneh Alavi, et al.
The Lancet (2023) Vol. 401, Iss. 10378, pp. 747-761
Closed Access | Times Cited: 190
Angiogenesis in Chronic Inflammatory Skin Disorders
Hyun Ji Lee, Yong Jun Hong, Miri Kim
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 12035-12035
Open Access | Times Cited: 131
BTK inhibitors in the treatment of hematological malignancies and inflammatory diseases: mechanisms and clinical studies
Aqu Alu, Hong Lei, Xuejiao Han, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 86
Secukinumab in Hidradenitis Suppurativa Patients Who Failed Adalimumab: A 52-Week Real-Life Study
Fabrizio Martora, Claudio Marasca, Sara Cacciapuoti, et al.
Clinical Cosmetic and Investigational Dermatology (2024) Vol. Volume 17, pp. 159-166
Open Access | Times Cited: 23
Proof-of-concept study exploring the effect of spesolimab in patients with moderate-to-severe hidradenitis suppurativa: a randomized double-blind placebo-controlled clinical trial
Afsáneh Alavi, Errol P. Prens, Alexa B. Kimball, et al.
British Journal of Dermatology (2024) Vol. 191, Iss. 4, pp. 508-518
Open Access | Times Cited: 16
Exploring the human hair follicle microbiome*
Marta B. Lousada, Tim Lachnit, J. Edelkamp, et al.
British Journal of Dermatology (2020) Vol. 184, Iss. 5, pp. 802-815
Closed Access | Times Cited: 100
Epithelialized tunnels are a source of inflammation in hidradenitis suppurativa
Kristina Navrazhina, John W. Frew, Patricia Gilleaudeau, et al.
Journal of Allergy and Clinical Immunology (2021) Vol. 147, Iss. 6, pp. 2213-2224
Open Access | Times Cited: 92
New and Emerging Targeted Therapies for Hidradenitis Suppurativa
Adela Markota Čagalj, Branka Marinović, Zrinka Bukvić Mokoš
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3753-3753
Open Access | Times Cited: 55
Identification of Biomarkers and Critical Evaluation of Biomarker Validation in Hidradenitis Suppurativa
Samuel A Der Sarkissian, Schapoor Hessam, Joslyn S. Kirby, et al.
JAMA Dermatology (2022) Vol. 158, Iss. 3, pp. 300-300
Open Access | Times Cited: 48
Teledermatology and Inflammatory Skin Conditions during COVID-19 Era: New Perspectives and Applications
Claudio Marasca, Maria Carmela Annunziata, Elisa Camela, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 6, pp. 1511-1511
Open Access | Times Cited: 48
Evolving approaches to profiling the microbiome in skin disease
Yang Chen, Rob Knight, Richard L. Gallo
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 31
Lipid Alterations and Metabolism Disturbances in Selected Inflammatory Skin Diseases
Julia Nowowiejska, Anna Baran, Iwona Flisiak
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7053-7053
Open Access | Times Cited: 29
Metformin has anti-inflammatory effects and induces immunometabolic reprogramming via multiple mechanisms in hidradenitis suppurativa
Andreea Petrasca, Róisín Hambly, Niamh Kearney, et al.
British Journal of Dermatology (2023) Vol. 189, Iss. 6, pp. 730-740
Open Access | Times Cited: 23
Emerging Role of the IL-36/IL-36R Axis in Multiple Inflammatory Skin Diseases
Fareed Ahmad, Majid Alam, Abdul W. Ansari, et al.
Journal of Investigative Dermatology (2024) Vol. 144, Iss. 2, pp. 206-224
Closed Access | Times Cited: 14
Deroofing: A safe, effective and well‐tolerated procedure in patients with hidradenitis suppurativa
Piotr Krajewski, V. Sanz‐Motilva, S. Flores Martinez, et al.
Journal of the European Academy of Dermatology and Venereology (2024) Vol. 38, Iss. 5, pp. 931-936
Closed Access | Times Cited: 9
Haptoglobin Genotypes in Hidradenitis Suppurativa: Haptoglobin 2–2 Genotype Is Associated With Familial Hidradenitis Suppurativa and More Flares
Nessr Abu Rached, Marina Skrygan, Lennart Ocker, et al.
International Journal of Dermatology (2025)
Open Access | Times Cited: 1
Acne in the first three decades of life: An update of a disorder with profound implications for all decades of life
Donald E. Greydanus, Roua Azmeh, Maria Demma Cabral, et al.
Disease-a-Month (2020) Vol. 67, Iss. 4, pp. 101103-101103
Closed Access | Times Cited: 50
Cytokine Pathways and Investigational Target Therapies in Hidradenitis Suppurativa
Ester Del Duca, Paola Morelli, Luigi Bennardo, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 22, pp. 8436-8436
Open Access | Times Cited: 50
New perspectives on the treatment of hidradenitis suppurativa
Victòria Amat‐Samaranch, Eugènia Agut‐Busquet, Eva Vilarrasa, et al.
Therapeutic Advances in Chronic Disease (2021) Vol. 12
Open Access | Times Cited: 49
Hidradenitis Suppurativa in the Pediatric Population
Carmen Liy‐Wong, Mary Kim, A. Yasmine Kirkorian, et al.
JAMA Dermatology (2021) Vol. 157, Iss. 4, pp. 385-385
Open Access | Times Cited: 47
Innate immunity and microbial dysbiosis in hidradenitis suppurativa – vicious cycle of chronic inflammation
Divya Chopra, Rachel A. Arens, Watcharee Amornpairoj, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 36
Colchicine in Managing Skin Conditions: A Systematic Review
Stefano Dastoli, Steven Paul Nisticò, Pietro Morrone, et al.
Pharmaceutics (2022) Vol. 14, Iss. 2, pp. 294-294
Open Access | Times Cited: 32
Incidence, Risk Factors, and Prognosis of Hidradenitis Suppurativa Across the Globe: Insights from the Literature
Hend Alotaibi
Clinical Cosmetic and Investigational Dermatology (2023) Vol. Volume 16, pp. 545-552
Open Access | Times Cited: 19
Short-Term Effectiveness, Safety, and Potential Predictors of Response of Secukinumab in Patients with Severe Hidradenitis Suppurativa Refractory to Biologic Therapy: A Multicenter Observational Retrospective Study
Pablo Fernández‐Crehuet, Sofía Haselgruber, Alicia Padial-Gómez, et al.
Dermatology and Therapy (2023) Vol. 13, Iss. 4, pp. 1029-1038
Open Access | Times Cited: 19
Hidradenitis Suppurativa Burdens on Mental Health: A Literature Review of Associated Psychiatric Disorders and Their Pathogenesis
Stefano Caccavale, Vittorio Tancredi, Maria Pia Boccellino, et al.
Life (2023) Vol. 13, Iss. 1, pp. 189-189
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top